| __timestamp | Arrowhead Pharmaceuticals, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 22223073 |
| Thursday, January 1, 2015 | 57410147 | 6966842 |
| Friday, January 1, 2016 | 41454452 | 9000499 |
| Sunday, January 1, 2017 | 31690298 | 13741186 |
| Monday, January 1, 2018 | 52968505 | 19040000 |
| Tuesday, January 1, 2019 | 81048686 | 23559000 |
| Wednesday, January 1, 2020 | 128874979 | 31931000 |
| Friday, January 1, 2021 | 206342000 | 44981000 |
| Saturday, January 1, 2022 | 297307000 | 54234000 |
| Sunday, January 1, 2023 | 353188000 | 63806000 |
| Monday, January 1, 2024 | 505870000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. has consistently outpaced Viking Therapeutics, Inc. in R&D investment. From 2014 to 2023, Arrowhead's R&D expenses surged by over 1,400%, peaking in 2023 with a remarkable 353 million USD. In contrast, Viking's R&D spending grew by approximately 187% during the same period, reaching 64 million USD in 2023.
This trend highlights Arrowhead's aggressive strategy to lead in innovation, while Viking maintains a more conservative approach. The data for 2024 is incomplete, but the trajectory suggests Arrowhead's continued dominance in R&D investment. As the biotech industry evolves, these spending patterns may influence future breakthroughs and market leadership.
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Genmab A/S vs Viking Therapeutics, Inc.
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
Blueprint Medicines Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.